Evidence map›Paper›PMID 32959223›Full record

Trial reportReproductive sciences (Thousand Oaks, Calif.)2021

Comparison of the Effect of Ceratonia siliqua L. (Carob) Syrup and Vitamin E on Sperm Parameters, Oxidative Stress Index, and Sex Hormones in Infertile Men: a Randomized Controlled Trial.

Mir Mohammad Reza Aghajani, Soleiman Mahjoub, Faraz Mojab, Mahshid Namdari, Neda Mahdinezhad Gorji, Afsaneh Dashtaki, Parvaneh Mirabi

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Reproductive sciences (Thousand Oaks, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mir Mohammad Reza AghajaniInfertility and Reproductive Health Research Center. Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-8391-729X
Soleiman MahjoubInfertility and Reproductive Health Research Center. Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0001-6899-0707
Faraz MojabPharmaceutical Sciences Research Center and School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2415-2175
Mahshid NamdariCommunity Oral Health Department, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-7069-6977
Neda Mahdinezhad GorjiInfertility and Reproductive Health Research Center. Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-5093-371X
Afsaneh DashtakiDepartment of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0003-4258-9047
Parvaneh MirabiInfertility and Reproductive Health Research Center. Health Research Institute, Babol University of Medical Sciences, Babol, Iran. parvaneh_mirabi@yahoo.com.ORCID 0000-0002-8077-3569
Babol University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal products with an antioxidant capacity can boost male reproductive functions. The empiric use of Ceratonia siliqua (carob) for its antioxidant properties is common among infertile men in Iran and Turkey. The objective of this study is to investigate the effects of C. siliqua (carob) on semen parameters, oxidative stress markers, and pregnancy rate in a parallel randomized, controlled study. A total of 60 infertile men with oligozoospermia, asthenospermia, and teratospermia were recruited from April 2018 to March 2019. Participants were divided randomly into the following two groups: carob syrup twice a day or vitamin E 100 mg twice a day for 3 months. Semen analysis was performed and hormonal levels and stress oxidative markers were measured in each treatment arm after 3 months. The quality of semen parameters improved in the carob group compared with Vit E semen count (p = 0.04 Cohen's d = .51), morphology (p = 0.001 Cohen's d = .93) and motility parameters (p = 0.002 Cohen's d = .90) were significantly higher in the carob group. No significant difference can be detected in post-treatment hormonal parameters and oxidative markers between groups, except for total antioxidant capacity(TAC) which was higher after post-treatment in carob group. A significantly higher pregnancy rate was found among the carob group. The administration of carob may be an effective agent for the improvement of semen parameters, probably related both to its involvement in the changing of testosterone level and to its antioxidant properties. Nevertheless, additional studies to evaluate the optimal dose and duration of treatment are needed. The trial has been registered in the Iranian Registry of Clinical Trials (Registration number: IRCT20171209037794N1.

Indexed as

FabaceaeAdultAntioxidantsBiomarkersFemaleFertility Agents, MaleFollicle Stimulating Hormone, HumanGalactansHormonesHumansInfertility, MaleIranLuteinizing HormoneMaleMannansOxidative StressAntioxidantsBiomarkersFertility Agents, MaleFollicle Stimulating Hormone, HumanGalactansHormoneslocust bean gumLuteinizing HormoneMannansPlant GumsTestosteroneVitamin ECeratonia siliqua (carob)Male infertilityOxidative stressPregnancyVitamin E

Identifiers

PMID32959223
OpenAlexW3087491322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.